Please assess the completion status of the following clinical trial:

Trial Title: A Study of the Effectiveness and Safety of Topiramate in the Treatment of Moderate to Severe Binge-eating Disorder Associated With Obesity

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2/PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of binge-eating disorder~* 3 or more binge days per week in the 2 weeks prior to baseline~* Obese (body mass index \>=30 and \<=50 kilograms per square meter)~* Uncomplicated/controlled Type II diabetes or hypertension are acceptable~* In generally good health~* If female capable of having children, using acceptable method of birth control~Exclusion Criteria:~* No current or past history of schizophrenia, other psychotic disorder, or bipolar disorder~* Significant depression that requires treatment with medication or therapy~* At risk to self or others~* No current or recent (within 3 months) diagnosis of abusing drugs or alcohol~* Initiation of formal psychiatric therapy in past 6 months for binge-eating disorder or any other psychiatric disorder~* Pregnant or breast-feeding~* No clinically significant medical condition

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).